This section of the website is for UK Healthcare Professionals only. 
If you are not a Healthcare Professional, please click here.

Identification and management of adverse reactions with cabozantinib in patients with advanced renal cell carcinoma

Renal Cell Carcinoma File
17 pages

A guide for healthcare professionals

CBZ-UK-000342 | November 2024

Identification and management of adverse reactions with cabozantinib in patients with advanced renal cell carcinoma
Explore more Renal Cell Carcinoma Resources

Explore more Renal Cell Carcinoma Resources

Browse